Latest stories on PMN
ProMIS jumps after early-stage trial data for Alzheimer’s therapy
Seeking Alpha67 · bullishproduct/pr
Chardan raises ProMIS Neurosciences stock price target on trial data
Investing.com Analyst Ratings63 · neutralanalyst
Why is ProMIS Neurosciences stock surging today?
Investing.com Markets50 · neutralgeneral
ProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results
InvestorsHub67 · bullishproduct/pr
At a glance: stocks gapping up premarket
Seeking Alpha50 · neutralgeneral
ProMIS Neurosciences stock jumps on trial safety data
Investing.com Markets67 · bullishproduct/pr
ProMIS Neurosciences Inc. (PMN) files 8-K
SEC 8-K50 · neutralgeneral
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
Business Insider56 · neutralproduct/pr
Chardan initiates ProMIS Neurosciences stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
ProMIS Neurosciences to Participate in Upcoming Conferences in June
Business Insider56 · neutralproduct/pr
ProMIS Neurosciences to Participate in Upcoming Conferences in June | PMN Stock News
StockTitan63 · neutralproduct/pr
PMN: [8-K] ProMIS Neurosciences Inc. Reports Material Event
StockTitan SEC50 · neutralgeneral